SCHEMBL740801

SCHEMBL740801

O=C(Nc1n[nH]c2sc(C(=O)N[C@H](CN3CCCCC3)c3ccccc3)cc12)c1ccc(F)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 13/20 0.60
CDC7 O00311 1/20 0.60
CHEK1 O14757 1/20 0.60
JAK2 O60674 1/20 0.60
PAK4 O96013 1/20 0.60
NTRK1 P04629 1/20 0.60
PRKCB P05771 1/20 0.60
INSR P06213 1/20 0.60
RET P07949 1/20 0.60
KIT P10721 1/20 0.60
FGFR1 P11362 1/20 0.60
PRKACA P17612 1/20 0.60
FLT4 P35916 1/20 0.60
KDR P35968 1/20 0.60
JAK3 P52333 1/20 0.60
PDK1 Q15118 1/20 0.60
AURKB Q96GD4 1/20 0.60
STK26 Q9P289 1/20 0.60
AURKC Q9UQB9 1/20 0.60
ROCK2 O75116 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL739474 0.99 AURKA (0.61) AURKACDC7CHEK1JAK2PAK4
SCHEMBL739912 0.92 AURKA (0.66) AURKACDC7CHEK1JAK2PAK4
SCHEMBL740790 0.88 AURKA (0.78) AURKACDC7CHEK1JAK2PAK4
SCHEMBL742866 0.87 AURKA (0.79) AURKACDC7CHEK1JAK2PAK4
SCHEMBL742091 0.86 AURKA (0.54) AURKACDC7CHEK1JAK2PAK4
SCHEMBL741931 0.86 AURKA (0.55) AURKACDC7CHEK1JAK2PAK4
SCHEMBL740552 0.85 AURKA (0.55) AURKACDC7CHEK1JAK2PAK4
SCHEMBL742869 0.84 AURKA (0.78) AURKACDC7CHEK1JAK2PAK4
SCHEMBL741347 0.83 AURKA (0.62) AURKACDC7CHEK1JAK2PAK4
SCHEMBL739860 0.81 AURKA (0.79) AURKACDC7CHEK1JAK2PAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed